Assays / Sexually transmitted infections

Sexually transmitted infections

Chlamydia trachomatis Fluorescent Antigen Assay

Part of the planned inSTIcheck™ line: a swab-based antigen test designed to detect current chlamydia infection at the point of care.

PlannedinSTIcheck™

At a glance

Target

Chlamydia trachomatis antigen

Sample

Swab

Readout

Instrument-read, logged automatically

Status

Planned · inSTIcheck™

Why it matters

Clinical context

Chlamydia is the most commonly reported bacterial STI in the United States and usually causes no symptoms, yet untreated infection can lead to infertility. Detecting the organism’s antigen from a swab points to current infection, which an antibody result cannot reliably show.

How OncoFirm will measure it

Built on the OncoFirm fluorescent platform

Designed to pair with gonorrhea

The chlamydia and gonorrhea tests are planned to run from the same kind of swab on the same reader.

A strip that checks itself

Every strip carries a fluorescent reference line of known brightness. Reading the test line against it corrects for reader and temperature drift, and the reader flags runs that did not flow correctly.

A traceable digital record

Each result is stored with the date, operator and lot, ready to share with a clinic record or laboratory system instead of being retyped by hand.

Where it's headed

Development roadmap

01

Feasibility

Antibody pairs, fluorescent conjugates and strip layout are selected and tested against the target.

Current focus

02

Assay development

Strip, reagents and reader settings are optimized, and pilot lots are built.

Next

03

Analytical validation

Precision, linearity, interference and lot-to-lot consistency are measured against reference methods.

Next

04

Clinical evaluation and launch

Performance is evaluated with clinical samples. First release is planned for research use only, followed by regulatory submissions.

Next

Development status. This assay and the OncoFirm platform are in development. They have not been cleared or approved by the FDA and are not available for sale. First products are planned for research use only. Descriptions reflect design goals, not demonstrated performance.

Partner on this assay

We welcome research, clinical, manufacturing and distribution partners. Tell us how this assay fits your work.